AI Article Synopsis
- Obesity is expected to impact 17.5% of adults and 400 million children worldwide by 2035, necessitating personalized and multidisciplinary treatment strategies.
- While lifestyle changes, medications, and bariatric surgery can aid in weight management, long-term success remains low, with surgery being the most effective yet underutilized option.
- The intragastric balloon (IGB) presents a minimally invasive alternative for weight management, having received approval from major regulatory authorities, and its ongoing development and historical significance are explored in the review.
Article Abstract
Obesity is escalating, projected to affect 17.5% of adults globally and afflict 400 million children by 2035. Managing this intricate and chronic condition demands personalized, multidisciplinary approaches. While dietary changes, lifestyle modifications, and medications yield short-term results, long-term outcomes are often poor, with bariatric surgery standing out as the most effective option. However, only a small fraction undergoes surgery due to various barriers. Intragastric balloon (IGB) emerges as a minimally invasive alternative, approved by major regulatory bodies. This review adresses the pivotal role of IGB in obesity management, delving into its history and technological evolution.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.giec.2024.04.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!